Skip to main content
. 2022 Mar 14;36(2):121–135. doi: 10.1007/s40259-022-00520-2

Fig. 1.

Fig. 1

Schematic representation of the putative mode of action of angiopoietin-like protein 3 (ANGPTL3) and apolipoprotein C-III (apoC-III) inhibition on lipoprotein transport in the circulation in humans